Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial

被引：0
|
作者：
Yongliang Feng
Jing Chen
Tian Yao
Yue Chang
Xiaoqing Li
Rongqin Xing
Hong Li
Ruixue Xie
Xiaohong Zhang
Zhiyun Wei
Shengcai Mu
Ling Liu
Lizhong Feng
Suping Wang
机构：
[1] Shanxi Medical University,Department of Epidemiology, School of Public Health
[2] Shanxi Medical University,Center of Clinical Epidemiology and Evidence Based Medicine
[3] Shanxi Provincial Center for Disease Control and Prevention,undefined
[4] Shanxi Provincial Key Laboratory for Major Infectious Disease Response,undefined
[5] Outpatient Department of Shanxi Aviation Industry Group Co. LTD,undefined
来源：
Infectious Diseases of Poverty | / 10卷
关键词：
COVID-19; Inactivated SARS-CoV-2 vaccine; Immunogenicity; Safety; High-risk occupational population; Randomized controlled trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adults
    Yassini, Patrick
    Hutchens, Mark
    Paila, Yamuna D.
    Schoch, Lorraine
    Aunins, Anne
    Siangphoe, Uma
    Paris, Robert
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [32] Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies
    Balgos, Abundio
    Hannawi, Suad
    Chen, Wen-Li
    Abuquta, Alaa
    Safeldin, Linda
    Hassan, Aala
    Alamadi, Ahmad
    Tirador, Louie
    Jaen, Anjuli May
    Villalobos, Ralph Elvi
    Mo, Chen
    Yue, Zi-Jing
    Ma, Ying
    Wang, Qing-Shuang
    Wen, Ren-Du
    Yao, Zheng
    Yu, Jia-Ping
    Yao, Wen-Rong
    Zhang, Jian-Hui
    Hong, Kun-Xue
    Liu, Yong
    Li, Jing-Xin
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 419 - 431
  • [33] Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial
    Guo, Wanshen
    Duan, Kai
    Zhang, Yuntao
    Yuan, Zhiming
    Zhang, Yan-Bo
    Wang, Zejun
    Zhao, Dongyang
    Zhang, Huajun
    Xie, Zhiqiang
    Li, Xinguo
    Peng, Cheng
    Zhang, Wei
    Yang, Yunkai
    Chen, Wei
    Gao, Xiaoxiao
    You, Wangyang
    Wang, Xue-Wei
    Shi, Zhengli
    Wang, Yanxia
    Yang, Xu-Qin
    Zhang, Lianghao
    Huang, Lili
    Wang, Qian
    Lu, Jia
    Yang, Yong-Li
    Guo, Jing
    Zhou, Wei
    Wan, Xin
    Wu, Cong
    Wang, Wenhui
    Du, Jianhui
    Nian, Xuanxuan
    Li, Xing-Hang
    Huang, Shihe
    Shen, Shuo
    Xia, Shengli
    Pan, An
    Yang, Xiaoming
    ECLINICALMEDICINE, 2021, 38
  • [34] Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people with gastrointestinal cancer
    Li, Tong
    Song, Rui
    Wang, Jingjie
    Zhang, Jianbo
    Cai, Hongxing
    He, Hongmei
    Hu, Wei
    Yu, Dajun
    Wang, Chuanhu
    Pan, Qingbo
    Peng, Mingli
    Ren, Hong
    Zhu, Peng
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 122 : 874 - 884
  • [35] Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
    Ao, Ling
    Lu, Ting
    Cao, Yu
    Chen, Zhiwei
    Wang, Yuting
    Li, Zisheng
    Ren, Xingqian
    Xu, Pan
    Peng, Mingli
    Chen, Min
    Zhang, Gaoli
    Xiang, Dejuan
    Cai, Dachuan
    Hu, Peng
    Shi, Xiaofeng
    Zhang, Dazhi
    Ren, Hong
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 1126 - 1134
  • [36] Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine KCONVAC in Chinese Children: Randomized, Double-blind, Placebo-controlled Phase 1 and 2 Trials
    Liu, Jiankai
    Huang, Baoying
    Li, Guifan
    Huang, Tao
    Wang, Danni
    Zhang, Li
    Deng, Yao
    Chang, Xianyun
    Liu, Yafei
    Li, Weiqi
    Zhang, Siyuan
    Huang, Weijin
    Tan, Wenjie
    Gao, Lidong
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (12) : 1136 - 1142
  • [37] Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine
    Romanee Chaiwarith
    Poramed Winichakoon
    Parichat Salee
    Tavitiya Sudjaritruk
    Jiraprapa Wipasa
    Kriangkrai Chawansuntati
    Saowaluck Yasri
    Harit Thongwitokomarn
    Kawisara Krasaewes
    Sethawut Ruangsirinusorn
    Jutarat Praparattanapan
    Nuttarika Solai
    Khanuengnit Nuket
    Darakorn Boonmee
    Orapin Chaichana
    Oramai Mueangmo
    Jutamad Saheng
    Worawan Wongjak
    Scientific Reports, 13
  • [38] Safety and immunogenicity of the third and fourth doses of vaccine against SARS-CoV-2 following a 2-dose regimen of inactivated whole-virion SARS-CoV-2 vaccine
    Chaiwarith, Romanee
    Winichakoon, Poramed
    Salee, Parichat
    Sudjaritruk, Tavitiya
    Wipasa, Jiraprapa
    Chawansuntati, Kriangkrai
    Yasri, Saowaluck
    Thongwitokomarn, Harit
    Krasaewes, Kawisara
    Ruangsirinusorn, Sethawut
    Praparattanapan, Jutarat
    Solai, Nuttarika
    Nuket, Khanuengnit
    Boonmee, Darakorn
    Chaichana, Orapin
    Mueangmo, Oramai
    Saheng, Jutamad
    Wongjak, Worawan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [39] Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
    Ella, Raches
    Vadrevu, Krishna Mohan
    Jogdand, Harsh
    Prasad, Sai
    Reddy, Siddharth
    Sarangi, Vamshi
    Ganneru, Brunda
    Sapkal, Gajanan
    Yadav, Pragya
    Abraham, Priya
    Panda, Samiran
    Gupta, Nivedita
    Reddy, Prabhakar
    Verma, Savita
    Rai, Sanjay Kumar
    Singh, Chandramani
    Redkar, Sagar Vivek
    Gillurkar, Chandra Sekhar
    Kushwaha, Jitendra Singh
    Mohapatra, Satyajit
    Rao, Venkat
    Guleria, Randeep
    Ella, Krishna
    Bhargava, Balram
    LANCET INFECTIOUS DISEASES, 2021, 21 (05): : 637 - 646
  • [40] Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial
    Kaabi, Nawal Al
    Yang, Yun Kai
    Liang, Yu
    Xu, Ke
    Zhang, Xue Feng
    Kang, Yun
    Jin, Yu Qin
    Hou, Jun Wei
    Zhang, Jing
    Yang, Tian
    Hussein, Salah
    ElDein, Mohamed Saif
    Lei, Ze Hua
    Zhang, Hao
    Shao, Shuai
    Liu, Zhao Ming
    Liu, Ning
    Zheng, Xiang
    Su, Ji Guo
    Yang, Sen Sen
    Cong, Xiangfeng
    Tan, Yao
    Lei, Wenwen
    Gao, Xue Jun
    Jiang, Zhiwei
    Wang, Hui
    Li, Meng
    Mekki, Hanadi Mekki
    Zaher, Walid
    Mahmoud, Sally
    Zhang, Xue
    Qu, Chang
    Liu, Dan Ying
    Yang, Mengjie
    Eltantawy, Islam
    Xiao, Peng
    Shen, Fu Jie
    Wu, Jin Juan
    Han, Zi Bo
    Du, Li Fang
    Tang, Fang
    Chen, Shi
    Ma, Zhi Jing
    Zheng, Fan
    Hou, Ya Nan
    Li, Xin Yu
    Li, Xin
    Wang, Zhao Nian
    Yin, Jin Liang
    Mao, Xiao Yan
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
12345